Heterogeneity of HPA-3 alloantibodies: consequences for the diagnosis of alloimmune thrombocytopenic syndromes

被引:33
作者
Socher, Ines
Zwingel, Claudia
Santoso, Sentot
Kroll, Hartmut [1 ]
机构
[1] Inst Transfus Med Dessau, Red Cross Blood Transfus Serv NSTOB, D-06847 Dessau, Germany
关键词
D O I
10.1111/j.1537-2995.2007.01550.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Immunization against the human platelet alloantigen (HPA)-3a residing on alpha IIb beta 3 integrin accounts for approximately 2 percent of fetal and neonatal alloimmune thrombocytopenia (FNAIT). Anti-HPA-3a alloantibodies are sometimes difficult to detect and can be overlooked by standard antigen capture assays. STUDY DESIGN AND METHODS: The reactivity of 12 anti-HPA-3a and 2 anti-HPA-3b alloantibodies from patients with FNAIT and posttransfusion purpura was analyzed by serologic (monoclonal antibody-specific immobilization of platelet antigens [MAIPA] assay, flow cytometry) and immunochemical (immunoprecipitation, immunoblotting) techniques. The influence of platelet (PLT) age, storage conditions, recombinant antigens from Chinese hamster ovary (CHO) cells, and sialic acids ( treatment with neuraminidase) were analyzed. RESULTS: The most sensitive anti-HPA-3 alloantibody detection in MAIPA assay could be achieved with fresh homozygous PLTs. During a PLT storage period of 14 days before use, three types of anti-HPA-3 alloantibodies were found: 1) complete loss of reactivity (n = 6), 2) considerably weakened reaction (>= 50% reduction; n = 3), and 3) minor reduction of reactivity (<= 40% decrease; n = 5). When cryopreserved PLTs were used, 10 of 12 anti-HPA-3a and all anti-HPA-3b alloantibodies reacted positive. Only 6 of 10 serum samples reacted with recombinant HPA-3a on CHO cells. Neuraminidase treatment of PLTs showed that some anti-HPA-3a alloantibodies require the presence of sialic acids. The storage lesion seems to be related to cleavage of sialic acids. Immunochemical analysis revealed evidence that most anti-HPA-3a alloantibodies require an intact three-dimensional aIIbb3 integrin structure. CONCLUSIONS: Anti-HPA- 3 alloantibodies show considerable heterogeneity, which may hamper the serologic diagnosis of FNAIT. Preservation of the aIIbb3 integrin and protection from enzymatic degradation seem to be important during PLT storage.
引用
收藏
页码:463 / 472
页数:10
相关论文
共 36 条
[1]   STUDIES ON A PATIENT WITH THROMBOCYTOPENIA, GIANT PLATELETS AND A PLATELET MEMBRANE GLYCOPROTEIN IB WITH REDUCED AMOUNT OF SIALIC-ACID [J].
AAKHUS, AM ;
STAVEM, P ;
HOVIG, T ;
PEDERSEN, TM ;
SOLUM, NO .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) :320-329
[2]  
Andersen Dana C., 1994, Current Opinion in Biotechnology, V5, P546, DOI 10.1016/0958-1669(94)90072-8
[3]   Severe neonatal alloimmune thrombocytopenia due to Anti-HPA-3a [J].
Boehlen, F ;
Kaplan, C ;
de Moerloose, P .
VOX SANGUINIS, 1998, 74 (03) :201-204
[4]   FURTHER-STUDIES ON THE TOPOGRAPHY OF HUMAN PLATELET GLYCOPROTEIN-IIB - LOCALIZATION OF MONOCLONAL-ANTIBODY EPITOPES AND THE PUTATIVE GLYCOPROTEIN IIIA- AND FIBRINOGEN-BINDING REGIONS [J].
CALVETE, JJ ;
ARIAS, J ;
ALVAREZ, MV ;
LOPEZ, MM ;
HENSCHEN, A ;
GONZALEZRODRIGUEZ, J .
BIOCHEMICAL JOURNAL, 1991, 273 :767-775
[5]   Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia [J].
Davoren, A ;
Curtis, BR ;
Aster, RH ;
McFarland, JG .
TRANSFUSION, 2004, 44 (08) :1220-1225
[6]  
DJAFFAR I, 1993, THROMB HAEMOSTASIS, V69, P485
[7]   Anti-HPA-3A induces severe neonatal alloimmune thrombocytopenia [J].
Glade-Bender, J ;
McFarland, JG ;
Kaplan, C ;
Porcelijn, L ;
Bussel, JB .
JOURNAL OF PEDIATRICS, 2001, 138 (06) :862-867
[8]  
GOLDBERGER A, 1991, BLOOD, V78, P681
[9]   Severe neonatal alloimmune thrombocytopenia caused by antibodies to human platelet antigen 3a (Baka) detectable only in whole platelet assays [J].
Harrison, CR ;
Curtis, BR ;
McFarland, JG ;
Huff, RW ;
Aster, RH .
TRANSFUSION, 2003, 43 (10) :1398-1402
[10]   Integrins: Bidirectional, allosteric signaling machines [J].
Hynes, RO .
CELL, 2002, 110 (06) :673-687